Peptide Synthesis

An internally quenched fluorogenic peptide substrate containing the C-terminal &#946-APP (amyloid &#946-peptide precursor protein) amino acid sequence that is cleaved by &#947-secretase. Shown to be sensitive and useful for assaying

Immunogen 14 amino acids near the carboxy terminus of human GL. Application Used as a blocking peptide in immunoblotting applications.

Glaucine (O,O-Dimethylisoboldine) is an alkaloid isolated from Glaucium flavum with antitussive, bronchodilation and anti-inflammatory properties. Glaucine is a selective and orally active phosphodiesterase 4 (PDE4) inhibitor with K i s of 3.4 µM in

Glaucine (O,O-Dimethylisoboldine) is an alkaloid isolated from Glaucium flavum with antitussive, bronchodilation and anti-inflammatory properties. Glaucine is a selective and orally active phosphodiesterase 4 (PDE4) inhibitor with K i s of 3.4 µM in

Glaucine (O,O-Dimethylisoboldine) is an alkaloid isolated from Glaucium flavum with antitussive, bronchodilation and anti-inflammatory properties. Glaucine is a selective and orally active phosphodiesterase 4 (PDE4) inhibitor with K i s of 3.4 µM in

Glukagon-Like Peptide 1 (GLP-1) (7-36)-Lys (Biotin), amide, human is an C-terminal-labelled biotinylated GLP-1 (7-36) amide.Appearance:SolidBiological Activity:Glukagon-Like Peptide 1 (GLP-1) (7-36)-Lys (Biotin), amide, human is an

Glukagon-Like Peptide 1 (GLP-1) (7-36)-Lys (Biotin), amide, human is an C-terminal-labelled biotinylated GLP-1 (7-36) amide.Appearance:SolidBiological Activity:Glukagon-Like Peptide 1 (GLP-1) (7-36)-Lys (Biotin), amide, human is an

Amino Acid Sequence His-Ala-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-Ser-Tyr-Leu-Glu-Gly-Gln-Ala-Ala-Lys-Glu-Phe-Ile-Ala-Trp-Leu-Val-Lys-Gly-Arg-NH2 General description Glucagon-like peptide 1 (GLP-1) peptide is obtained from proglucagon and is

Nanocs' amino acid and peptide PEG conjugates were made from the covalent attachment of PEG to various amino acid derivatives. Conjugates were provided in lyophilized powder form.

Nanocs' amino acid and peptide PEG conjugates were made from the covalent attachment of PEG to various amino acid derivatives. Conjugates were provided in lyophilized powder form.

Nanocs' amino acid and peptide PEG conjugates were made from the covalent attachment of PEG to various amino acid derivatives. Conjugates were provided in lyophilized powder form.

Nanocs' amino acid and peptide PEG conjugates were made from the covalent attachment of PEG to various amino acid derivatives. Conjugates were provided in lyophilized powder form.